JP2024532845A5 - - Google Patents
Info
- Publication number
- JP2024532845A5 JP2024532845A5 JP2024510224A JP2024510224A JP2024532845A5 JP 2024532845 A5 JP2024532845 A5 JP 2024532845A5 JP 2024510224 A JP2024510224 A JP 2024510224A JP 2024510224 A JP2024510224 A JP 2024510224A JP 2024532845 A5 JP2024532845 A5 JP 2024532845A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- optionally substituted
- substituted
- cancer
- alternatively
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2021112906 | 2021-08-17 | ||
| CNPCT/CN2021/112906 | 2021-08-17 | ||
| PCT/CN2022/112674 WO2023020457A1 (en) | 2021-08-17 | 2022-08-16 | Pyridazinone or pyridinone compounds, preparation methods and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024532845A JP2024532845A (ja) | 2024-09-10 |
| JP2024532845A5 true JP2024532845A5 (https=) | 2025-08-13 |
Family
ID=85240081
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024510224A Pending JP2024532845A (ja) | 2021-08-17 | 2022-08-16 | ピリダジノンまたはピリジノン化合物、その製造方法および用途 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240343727A1 (https=) |
| EP (1) | EP4387966A4 (https=) |
| JP (1) | JP2024532845A (https=) |
| CN (1) | CN117897380A (https=) |
| WO (1) | WO2023020457A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2022375782B2 (en) * | 2021-10-28 | 2026-02-26 | Gilead Sciences, Inc. | Pyridizin-3(2h)-one derivatives |
| JP2025534359A (ja) * | 2022-09-30 | 2025-10-15 | アズカラ セラピューティクス インク | ピリダジン－３（２ｈ）－オンおよびピリジン－２（１ｈ）－オンのＰＡＲＰ阻害化合物 |
| GB202217888D0 (en) * | 2022-11-29 | 2023-01-11 | Duke Street Bio Ltd | Pharmaceutical compound |
| TW202430518A (zh) * | 2023-01-06 | 2024-08-01 | 大陸商齊魯製藥有限公司 | Parp7抑制劑的製備方法 |
| CN116874496B (zh) * | 2023-07-10 | 2025-07-25 | 东南大学 | 三环类化合物及其制备方法、药物组合物和应用 |
| CN117777099A (zh) * | 2023-12-26 | 2024-03-29 | 诺沃斯达药业(上海)有限公司 | Parp7抑制剂及其用途 |
| CN118772063B (zh) * | 2024-07-04 | 2025-06-13 | 西北师范大学 | 一种四氢哒嗪类化合物的合成方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19921567A1 (de) * | 1999-05-11 | 2000-11-16 | Basf Ag | Verwendung von Phthalazine-Derivaten |
| GB0419072D0 (en) * | 2004-08-26 | 2004-09-29 | Kudos Pharm Ltd | Phthalazinone derivatives |
| GB0610680D0 (en) * | 2006-05-31 | 2006-07-12 | Istituto Di Ricerche D Biolog | Therapeutic compounds |
| UY31603A1 (es) * | 2008-01-23 | 2009-08-31 | Derivados de ftalazinona | |
| CN103130723B (zh) * | 2011-11-30 | 2015-01-14 | 成都地奥制药集团有限公司 | 一种多聚(adp-核糖)聚合酶抑制剂 |
| JP7346425B2 (ja) * | 2018-01-11 | 2023-09-19 | セントラス セラピューティクス | 疾患を治療するためのジヒドロセラミドデサチュラーゼ阻害剤 |
| FI3788040T3 (fi) * | 2018-04-30 | 2023-06-13 | Ribon Therapeutics Inc | Pyridatsinoneja parp7-inhibiittoreina |
| CA3113373A1 (en) * | 2018-10-12 | 2020-04-16 | InventisBio Co., Ltd. | Thyroid hormone receptor agonists |
| US20240190844A1 (en) * | 2019-10-30 | 2024-06-13 | Ribon Therapeutics, Inc. | Pyridazinones as parp7 inhibitors |
-
2022
- 2022-08-16 CN CN202280055111.5A patent/CN117897380A/zh active Pending
- 2022-08-16 EP EP22857769.8A patent/EP4387966A4/en active Pending
- 2022-08-16 JP JP2024510224A patent/JP2024532845A/ja active Pending
- 2022-08-16 WO PCT/CN2022/112674 patent/WO2023020457A1/en not_active Ceased
- 2022-08-16 US US18/578,677 patent/US20240343727A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024532845A5 (https=) | ||
| EP4001276B1 (en) | Aurora kinase inhibitor and use thereof | |
| JP2025160318A5 (https=) | ||
| JP2024522766A5 (https=) | ||
| JP2024530495A5 (https=) | ||
| JP2024099041A5 (https=) | ||
| BG64838B1 (bg) | Производни на индолил-3-глиоксиловата киселина с антитуморно действие | |
| JP2023520333A5 (https=) | ||
| JP2007511504A5 (https=) | ||
| JP2019519476A5 (https=) | ||
| JP2021523225A5 (https=) | ||
| JP2022526266A5 (https=) | ||
| JP2018524403A5 (https=) | ||
| JP2020063289A5 (https=) | ||
| JP2021514395A5 (https=) | ||
| JP2015518011A (ja) | ピロロ［２，１−ｆ］［１，２，４］トリアジン誘導体およびその抗腫瘍用途 | |
| JP2022541747A5 (https=) | ||
| JP2002509930A (ja) | ベンゾ複素環ジスタマイシン誘導体、その製造方法および抗腫瘍薬としてのそれの使用 | |
| JP2020502116A5 (https=) | ||
| JP2019504833A5 (https=) | ||
| JP2012502912A (ja) | Ｎ−［６−（ｃｉｓ−２，６−ジメチルモルホリン−４−イル）ピリジン−３−イル］−２−メチル−４’−（トリフルオロメトキシ）［１，１’−ビフェニル］−３−カルボキサミドの塩 | |
| JP2007532628A5 (https=) | ||
| BRPI0509912B1 (pt) | compostos, processo para a preparação dos mesmos, composição farmacêutica, e, uso de um composto | |
| JP2021532158A5 (https=) | ||
| JP2023542065A5 (https=) |